Review



drug treatment human breast cancer cell lines mcf 7  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC drug treatment human breast cancer cell lines mcf 7
    Drug Treatment Human Breast Cancer Cell Lines Mcf 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 38990 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/drug treatment human breast cancer cell lines mcf 7/product/ATCC
    Average 99 stars, based on 38990 article reviews
    drug treatment human breast cancer cell lines mcf 7 - by Bioz Stars, 2026-03
    99/100 stars

    Images



    Similar Products

    99
    ATCC drug treatment human breast cancer cell lines mcf 7
    Drug Treatment Human Breast Cancer Cell Lines Mcf 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/drug treatment human breast cancer cell lines mcf 7/product/ATCC
    Average 99 stars, based on 1 article reviews
    drug treatment human breast cancer cell lines mcf 7 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC human breast cancer cell lines mcf7
    Human Breast Cancer Cell Lines Mcf7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human breast cancer cell lines mcf7/product/ATCC
    Average 99 stars, based on 1 article reviews
    human breast cancer cell lines mcf7 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC human breast cancer cell line mcf 7
    Human Breast Cancer Cell Line Mcf 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human breast cancer cell line mcf 7/product/ATCC
    Average 99 stars, based on 1 article reviews
    human breast cancer cell line mcf 7 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC chemicals human breast cancer cell lines
    Chemicals Human Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chemicals human breast cancer cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    chemicals human breast cancer cell lines - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC human breast cancer cell lines
    Human Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human breast cancer cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    human breast cancer cell lines - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC mcf 7 human breast cancer cell line
    Characterization of YAP/β-catenin expression and proliferation rate in breast cancer cells when subject to different stiffness (A) Random field of view images were taken under brightfield with a magnification of 20× <t>of</t> <t>MCF-7</t> and MDA-MB-231 cells. Scale bars = 100 μm (B) Proliferation rates of MCF-7 and MDA-MB-231 cells on the substrate with different stiffness were measured using alamarBlue Cell viability reagent over the course of 8 days. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ∗ p < 0.05, ∗∗∗∗ p < 0.0001. (C) Western blot results of YAP and β-catenin in MCF-7 and MDA-MB-231 cells that were subject to 2 kPa and 32 kPa substrate. Protein expression of β-catenin, YAP, and pYAP was analyzed with GAPDH used for normalization.
    Mcf 7 Human Breast Cancer Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mcf 7 human breast cancer cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    mcf 7 human breast cancer cell line - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC human breast cancer cell line mcf7
    Vimentin expression is a determinant of EAV susceptibility. ( A ) EAV replication kinetics were evaluated in equine (EECs, E. Derm) and non-equine cell lines (BHK-21, HP-RK-13, HEK-293, <t>MCF7,</t> and DLD-1) following infection at a multiplicity of infection (MOI) of 1. ( B ) Immunofluorescence microscopy of EECs E. Derm, DLD-1, and MCF7 cells infected for 12 h with EAV sVBSmCherry and stained with EAV anti-nsp1 MAb (clone 12A4; green), to detect virus replication. Nuclei were counterstained with DAPI (gray). Scale bars = 50 µm. ( C ) Vimentin expression levels were assessed by Western blot. VIM = vimentin. ( D ) Relative quantification of vimentin expression from Western blot analysis. Vimentin levels are expressed as the ratio of each band to β-actin. ( E ) Surface expression of vimentin was quantified by flow cytometry. MFI: Mean Fluorescence Intensity. ( F ) Immunofluorescence microscopy of EECs, E. Derm, DLD-1 and MCF7 cells stained with anti-vimentin MAb (Clone V9) to detect intracellular vimentin (green). Nuclei were counterstained with DAPI (gray). Scale bars = 50 µm. ( G ) Binding assay performed on EECs, E. Derm, DLD-1, and MCF7 cells, with infectious virus titers measured 1 h post-infection at 4 °C. ( H ) Protein alignment of Vimentin from susceptible species and species where a cell line was identified as susceptible to EAV infection. Values represent the percentage of similarity. Equus caballus , horse, GenBank number: NP_001230074 ; Equus asinus , donkey, GenBank number: XP_014701524 ; Homo sapiens , human, GenBank number: NP_035831 ; Chlorocebus aethiops , African green monkey, GenBank number: ABA39528 ; Oryctolagus cuniculus , rabbit, GenBank number: XP_002717466 ; Mus musculus , mouse, GenBank number: NP_035831 ; and Mesocricetus auratus , hamster, GenBank number: XP_005081318 . Data represent the mean ± standard deviation from three independent experiments. *, p < 0.05; **, p < 0.01.
    Human Breast Cancer Cell Line Mcf7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human breast cancer cell line mcf7/product/ATCC
    Average 99 stars, based on 1 article reviews
    human breast cancer cell line mcf7 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    Image Search Results


    Characterization of YAP/β-catenin expression and proliferation rate in breast cancer cells when subject to different stiffness (A) Random field of view images were taken under brightfield with a magnification of 20× of MCF-7 and MDA-MB-231 cells. Scale bars = 100 μm (B) Proliferation rates of MCF-7 and MDA-MB-231 cells on the substrate with different stiffness were measured using alamarBlue Cell viability reagent over the course of 8 days. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ∗ p < 0.05, ∗∗∗∗ p < 0.0001. (C) Western blot results of YAP and β-catenin in MCF-7 and MDA-MB-231 cells that were subject to 2 kPa and 32 kPa substrate. Protein expression of β-catenin, YAP, and pYAP was analyzed with GAPDH used for normalization.

    Journal: iScience

    Article Title: A stiffness-gated YAP-β-catenin axis orchestrates AXIN2 expression in metastatic breast cancer

    doi: 10.1016/j.isci.2025.114405

    Figure Lengend Snippet: Characterization of YAP/β-catenin expression and proliferation rate in breast cancer cells when subject to different stiffness (A) Random field of view images were taken under brightfield with a magnification of 20× of MCF-7 and MDA-MB-231 cells. Scale bars = 100 μm (B) Proliferation rates of MCF-7 and MDA-MB-231 cells on the substrate with different stiffness were measured using alamarBlue Cell viability reagent over the course of 8 days. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ∗ p < 0.05, ∗∗∗∗ p < 0.0001. (C) Western blot results of YAP and β-catenin in MCF-7 and MDA-MB-231 cells that were subject to 2 kPa and 32 kPa substrate. Protein expression of β-catenin, YAP, and pYAP was analyzed with GAPDH used for normalization.

    Article Snippet: MCF-7 human breast cancer cell line , ATCC , HTB-22; RRID: CVCL_0031.

    Techniques: Expressing, Western Blot

    YAP controls actin cytoskeletal organization and polymerization in a stiffness-dependent manner in metastatic breast cancer cells (A) MCF-7 and MDA-MB-231 cells were transfected with non-targeting control siRNAs (control) or siRNA against YAP (siYAP) for 48 h. Control group was treated with LatA at a concentration of 0.4 μM for 1 h (LatA). After the fixation, permeabilization, and blocking, the cells were stained for F-actin and G-actin. Images were taken using Cytation5 under 20× magnification. Scale bars = 50 μm (B) The quantification of the F/G actin ratio in MCF-7 cells (left) and MDA-MB-231 cells (right) from the images in A. Image analysis was performed using BioTek Gen5 Software, and bar graphs were created using GraphPad Prism. Data represent mean ± SD. n = individual cells pooled from 5 randomly acquired images per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ns: not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

    Journal: iScience

    Article Title: A stiffness-gated YAP-β-catenin axis orchestrates AXIN2 expression in metastatic breast cancer

    doi: 10.1016/j.isci.2025.114405

    Figure Lengend Snippet: YAP controls actin cytoskeletal organization and polymerization in a stiffness-dependent manner in metastatic breast cancer cells (A) MCF-7 and MDA-MB-231 cells were transfected with non-targeting control siRNAs (control) or siRNA against YAP (siYAP) for 48 h. Control group was treated with LatA at a concentration of 0.4 μM for 1 h (LatA). After the fixation, permeabilization, and blocking, the cells were stained for F-actin and G-actin. Images were taken using Cytation5 under 20× magnification. Scale bars = 50 μm (B) The quantification of the F/G actin ratio in MCF-7 cells (left) and MDA-MB-231 cells (right) from the images in A. Image analysis was performed using BioTek Gen5 Software, and bar graphs were created using GraphPad Prism. Data represent mean ± SD. n = individual cells pooled from 5 randomly acquired images per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ns: not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

    Article Snippet: MCF-7 human breast cancer cell line , ATCC , HTB-22; RRID: CVCL_0031.

    Techniques: Transfection, Control, Concentration Assay, Blocking Assay, Staining, Software

    Enhanced translocation of YAP and β-catenin to the nucleus occurs in response to a more rigid substrate in metastatic breast cancer cells (A) The intracellular distribution of β-catenin and YAP in MCF-7 and MDA-MB-231 cells, subjected to the substrates of 2 kPa and 32 kPa, was examined through immunofluorescent staining. Scale bars = 100 μm (B) YAP (top) and β-catenin (bottom) nuclear translocation was measured using BioTek Gen5 Software, and results were generated using GraphPad Prism. Data represent mean ± SD. n = individual cells pooled from 15 images (5 fields × 3 wells) per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ns: not significant, ∗∗∗∗ p < 0.0001.

    Journal: iScience

    Article Title: A stiffness-gated YAP-β-catenin axis orchestrates AXIN2 expression in metastatic breast cancer

    doi: 10.1016/j.isci.2025.114405

    Figure Lengend Snippet: Enhanced translocation of YAP and β-catenin to the nucleus occurs in response to a more rigid substrate in metastatic breast cancer cells (A) The intracellular distribution of β-catenin and YAP in MCF-7 and MDA-MB-231 cells, subjected to the substrates of 2 kPa and 32 kPa, was examined through immunofluorescent staining. Scale bars = 100 μm (B) YAP (top) and β-catenin (bottom) nuclear translocation was measured using BioTek Gen5 Software, and results were generated using GraphPad Prism. Data represent mean ± SD. n = individual cells pooled from 15 images (5 fields × 3 wells) per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ns: not significant, ∗∗∗∗ p < 0.0001.

    Article Snippet: MCF-7 human breast cancer cell line , ATCC , HTB-22; RRID: CVCL_0031.

    Techniques: Translocation Assay, Staining, Software, Generated

    β-catenin nuclear translocation following YAP knockdown is regulated by cell density in metastatic breast cancer cells (A) YAP and β-catenin in MDA-MB-231 cells at low, medium, and high confluency after YAP knockdown. Low confluency (30% confluency), medium confluency (50% confluency), and high confluency (80% confluency). MDA-MB-231 cells that were subject to 2 kPa and 32 kPa substrates were transfected with non-targeting siRNA (control) or siRNA against YAP (siYAP) before the immunofluorescent staining for YAP and β-catenin. Scale bars = 100 μm (B) The percentages of the cell population that show β-catenin nuclear translocation in A were measured in Agilent BioTek Gen 5 and plotted in GraphPad Prism. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ns: not significant, ∗ p < 0.05, ∗∗ p < 0.01. (C) The analysis of β-catenin and its active isoform expression in MCF-7 and MDA-MB-231 cells on 2 kPa and 32 kPa substrates following YAP knockdown. Total protein amount was used for normalization, and bar graphs were generated using GraphPad Prism. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ns: not significant.

    Journal: iScience

    Article Title: A stiffness-gated YAP-β-catenin axis orchestrates AXIN2 expression in metastatic breast cancer

    doi: 10.1016/j.isci.2025.114405

    Figure Lengend Snippet: β-catenin nuclear translocation following YAP knockdown is regulated by cell density in metastatic breast cancer cells (A) YAP and β-catenin in MDA-MB-231 cells at low, medium, and high confluency after YAP knockdown. Low confluency (30% confluency), medium confluency (50% confluency), and high confluency (80% confluency). MDA-MB-231 cells that were subject to 2 kPa and 32 kPa substrates were transfected with non-targeting siRNA (control) or siRNA against YAP (siYAP) before the immunofluorescent staining for YAP and β-catenin. Scale bars = 100 μm (B) The percentages of the cell population that show β-catenin nuclear translocation in A were measured in Agilent BioTek Gen 5 and plotted in GraphPad Prism. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ns: not significant, ∗ p < 0.05, ∗∗ p < 0.01. (C) The analysis of β-catenin and its active isoform expression in MCF-7 and MDA-MB-231 cells on 2 kPa and 32 kPa substrates following YAP knockdown. Total protein amount was used for normalization, and bar graphs were generated using GraphPad Prism. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ns: not significant.

    Article Snippet: MCF-7 human breast cancer cell line , ATCC , HTB-22; RRID: CVCL_0031.

    Techniques: Translocation Assay, Knockdown, Transfection, Control, Staining, Expressing, Generated

    β-catenin nuclear translocation upon YAP depletion supports cell proliferation and migration in metastatic breast cancer cells in a stiffness-dependent manner (A) Proliferation analysis of MCF-7 and MDA-MB-231 cells following YAP knockdown. Both MCF-7 cells and MDA-MB-231 cells were transfected with non-targeting siRNA (control), siRNA against YAP (siYAP), or siRNA against β-catenin (siβ-catenin). Then alamarBlue assay was performed for a period of 7 or 10 days at each time point for both MCF-7 cells and MDA-MB-231 cells. Then the data were generated using GraphPad Prism. Data represent mean ± SD. n = 3 wells per condition. (B) Cell migration analysis of MDA-MB-231 cells that were cultured on 2 kPa or 32 kPa substrates before the transfection with non-targeting siRNA (control), or siRNA against YAP (siYAP), or siRNA against YAP and siRNA against β-catenin (siYAP and siβ-catenin). Then the gap closure assay was performed, and the gap areas were imaged using Cytation5 under 4× magnification at 0 h and 20 h. Scale bars = 1000 μm (C) Quantitative analysis of the cell migration assay in B was conducted using ImageJ, and the results were generated using GraphPad Prism. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ns: not significant, ∗ p < 0.05.

    Journal: iScience

    Article Title: A stiffness-gated YAP-β-catenin axis orchestrates AXIN2 expression in metastatic breast cancer

    doi: 10.1016/j.isci.2025.114405

    Figure Lengend Snippet: β-catenin nuclear translocation upon YAP depletion supports cell proliferation and migration in metastatic breast cancer cells in a stiffness-dependent manner (A) Proliferation analysis of MCF-7 and MDA-MB-231 cells following YAP knockdown. Both MCF-7 cells and MDA-MB-231 cells were transfected with non-targeting siRNA (control), siRNA against YAP (siYAP), or siRNA against β-catenin (siβ-catenin). Then alamarBlue assay was performed for a period of 7 or 10 days at each time point for both MCF-7 cells and MDA-MB-231 cells. Then the data were generated using GraphPad Prism. Data represent mean ± SD. n = 3 wells per condition. (B) Cell migration analysis of MDA-MB-231 cells that were cultured on 2 kPa or 32 kPa substrates before the transfection with non-targeting siRNA (control), or siRNA against YAP (siYAP), or siRNA against YAP and siRNA against β-catenin (siYAP and siβ-catenin). Then the gap closure assay was performed, and the gap areas were imaged using Cytation5 under 4× magnification at 0 h and 20 h. Scale bars = 1000 μm (C) Quantitative analysis of the cell migration assay in B was conducted using ImageJ, and the results were generated using GraphPad Prism. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using one-way ANOVA followed by the Tukey post hoc test. ns: not significant, ∗ p < 0.05.

    Article Snippet: MCF-7 human breast cancer cell line , ATCC , HTB-22; RRID: CVCL_0031.

    Techniques: Translocation Assay, Migration, Knockdown, Transfection, Control, Alamar Blue Assay, Generated, Cell Culture, Cell Migration Assay

    Matrix stiffness modulates total and phosphorylated β-catenin levels in breast cancer cells (A) Representative Western blots of total β-catenin and phosphorylated β-catenin at S33/S37/T41 and S675 in MCF-7 and MDA-MB-231 cells cultured on soft (2 kPa) and stiff (32 kPa) substrates. (B) Quantification of protein levels normalized to loading controls (mean ± SD). Top row: Total β-catenin expression showed no significant differences across stiffness in MCF-7 cells but was significantly increased in MDA-MB-231 cells cultured on stiff (32 kPa) compared to soft (2 kPa) substrates (∗ p < 0.05). Middle row: Phosphorylation of β-catenin at S33/S37/T41 (associated with degradation) was significantly higher in MDA-MB-231 cells than in MCF-7 cells at both stiffness levels (∗∗ p < 0.01), indicating enhanced β-catenin degradation in the metastatic subtype. However, substrate stiffness had no significant effect on p-β-catenin (S33/S37/T41) within either cell line. Bottom row: Phosphorylation at S675 (associated with nuclear translocation) was significantly higher in MCF-7 cells than in MDA-MB-231 cells at both stiffness levels ∗∗∗ p < 0.001). Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using two-tailed t-tests. ns: not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: iScience

    Article Title: A stiffness-gated YAP-β-catenin axis orchestrates AXIN2 expression in metastatic breast cancer

    doi: 10.1016/j.isci.2025.114405

    Figure Lengend Snippet: Matrix stiffness modulates total and phosphorylated β-catenin levels in breast cancer cells (A) Representative Western blots of total β-catenin and phosphorylated β-catenin at S33/S37/T41 and S675 in MCF-7 and MDA-MB-231 cells cultured on soft (2 kPa) and stiff (32 kPa) substrates. (B) Quantification of protein levels normalized to loading controls (mean ± SD). Top row: Total β-catenin expression showed no significant differences across stiffness in MCF-7 cells but was significantly increased in MDA-MB-231 cells cultured on stiff (32 kPa) compared to soft (2 kPa) substrates (∗ p < 0.05). Middle row: Phosphorylation of β-catenin at S33/S37/T41 (associated with degradation) was significantly higher in MDA-MB-231 cells than in MCF-7 cells at both stiffness levels (∗∗ p < 0.01), indicating enhanced β-catenin degradation in the metastatic subtype. However, substrate stiffness had no significant effect on p-β-catenin (S33/S37/T41) within either cell line. Bottom row: Phosphorylation at S675 (associated with nuclear translocation) was significantly higher in MCF-7 cells than in MDA-MB-231 cells at both stiffness levels ∗∗∗ p < 0.001). Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using two-tailed t-tests. ns: not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: MCF-7 human breast cancer cell line , ATCC , HTB-22; RRID: CVCL_0031.

    Techniques: Western Blot, Cell Culture, Expressing, Phospho-proteomics, Translocation Assay, Two Tailed Test

    YAP knockdown selectively downregulates AXIN2 expression on soft substrates in metastatic breast cancer cells (A) Capillary-based immunoblot and quantification confirming efficient YAP knockdown in MDA-MB-231 cells cultured on soft (2 kPa) and stiff (32 kPa) substrates for 48 h. YAP protein levels were significantly reduced in siYAP-treated cells compared to control (∗∗∗∗ p < 0.0001). Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using two-way ANOVA followed by the Tukey post hoc test. (B) Immunoblot and quantification of CCND1 and AXIN2 protein expression in MDA-MB-231 and MCF-7 cells following YAP knockdown. In MDA-MB-231 cells, YAP depletion did not significantly affect CCND1 expression at either stiffness, while AXIN2 levels were significantly decreased under 2 kPa (∗ p < 0.05) but not 32 kPa. In MCF-7 cells, CCND1 expression was significantly elevated on stiff substrate compared to soft (∗ p < 0.05), independent of YAP knockdown. AXIN2 expression in MCF-7 cells was not significantly affected by YAP knockdown at either stiffness. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using two-way ANOVA followed by the Tukey post hoc test. ns: not significant.

    Journal: iScience

    Article Title: A stiffness-gated YAP-β-catenin axis orchestrates AXIN2 expression in metastatic breast cancer

    doi: 10.1016/j.isci.2025.114405

    Figure Lengend Snippet: YAP knockdown selectively downregulates AXIN2 expression on soft substrates in metastatic breast cancer cells (A) Capillary-based immunoblot and quantification confirming efficient YAP knockdown in MDA-MB-231 cells cultured on soft (2 kPa) and stiff (32 kPa) substrates for 48 h. YAP protein levels were significantly reduced in siYAP-treated cells compared to control (∗∗∗∗ p < 0.0001). Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using two-way ANOVA followed by the Tukey post hoc test. (B) Immunoblot and quantification of CCND1 and AXIN2 protein expression in MDA-MB-231 and MCF-7 cells following YAP knockdown. In MDA-MB-231 cells, YAP depletion did not significantly affect CCND1 expression at either stiffness, while AXIN2 levels were significantly decreased under 2 kPa (∗ p < 0.05) but not 32 kPa. In MCF-7 cells, CCND1 expression was significantly elevated on stiff substrate compared to soft (∗ p < 0.05), independent of YAP knockdown. AXIN2 expression in MCF-7 cells was not significantly affected by YAP knockdown at either stiffness. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using two-way ANOVA followed by the Tukey post hoc test. ns: not significant.

    Article Snippet: MCF-7 human breast cancer cell line , ATCC , HTB-22; RRID: CVCL_0031.

    Techniques: Knockdown, Expressing, Western Blot, Cell Culture, Control

    β-catenin knockdown reduces CTGF mRNA but not protein expression, and does not affect CCND1 expression (A) qPCR analysis showing efficient CTNNB1 knockdown and the CCND1 and CTGF transcript levels in MDA-MB-231 and MCF-7 cells. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using two-way ANOVA followed by the Tukey post hoc test. ns: not significant, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (B) Western blots and quantification confirm reduced β-catenin protein following siRNA treatment, but no significant change in CCND1 or CTGF protein expression. These results suggest that β-catenin alone is insufficient to regulate YAP target genes in the absence of YAP. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using two-way ANOVA followed by the Tukey post hoc test. ns: not significant, ∗∗∗∗ p < 0.0001.

    Journal: iScience

    Article Title: A stiffness-gated YAP-β-catenin axis orchestrates AXIN2 expression in metastatic breast cancer

    doi: 10.1016/j.isci.2025.114405

    Figure Lengend Snippet: β-catenin knockdown reduces CTGF mRNA but not protein expression, and does not affect CCND1 expression (A) qPCR analysis showing efficient CTNNB1 knockdown and the CCND1 and CTGF transcript levels in MDA-MB-231 and MCF-7 cells. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using two-way ANOVA followed by the Tukey post hoc test. ns: not significant, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (B) Western blots and quantification confirm reduced β-catenin protein following siRNA treatment, but no significant change in CCND1 or CTGF protein expression. These results suggest that β-catenin alone is insufficient to regulate YAP target genes in the absence of YAP. Data represent mean ± SD. n = 3 wells per condition. Statistical significance was assessed using two-way ANOVA followed by the Tukey post hoc test. ns: not significant, ∗∗∗∗ p < 0.0001.

    Article Snippet: MCF-7 human breast cancer cell line , ATCC , HTB-22; RRID: CVCL_0031.

    Techniques: Knockdown, Expressing, Western Blot

    Vimentin expression is a determinant of EAV susceptibility. ( A ) EAV replication kinetics were evaluated in equine (EECs, E. Derm) and non-equine cell lines (BHK-21, HP-RK-13, HEK-293, MCF7, and DLD-1) following infection at a multiplicity of infection (MOI) of 1. ( B ) Immunofluorescence microscopy of EECs E. Derm, DLD-1, and MCF7 cells infected for 12 h with EAV sVBSmCherry and stained with EAV anti-nsp1 MAb (clone 12A4; green), to detect virus replication. Nuclei were counterstained with DAPI (gray). Scale bars = 50 µm. ( C ) Vimentin expression levels were assessed by Western blot. VIM = vimentin. ( D ) Relative quantification of vimentin expression from Western blot analysis. Vimentin levels are expressed as the ratio of each band to β-actin. ( E ) Surface expression of vimentin was quantified by flow cytometry. MFI: Mean Fluorescence Intensity. ( F ) Immunofluorescence microscopy of EECs, E. Derm, DLD-1 and MCF7 cells stained with anti-vimentin MAb (Clone V9) to detect intracellular vimentin (green). Nuclei were counterstained with DAPI (gray). Scale bars = 50 µm. ( G ) Binding assay performed on EECs, E. Derm, DLD-1, and MCF7 cells, with infectious virus titers measured 1 h post-infection at 4 °C. ( H ) Protein alignment of Vimentin from susceptible species and species where a cell line was identified as susceptible to EAV infection. Values represent the percentage of similarity. Equus caballus , horse, GenBank number: NP_001230074 ; Equus asinus , donkey, GenBank number: XP_014701524 ; Homo sapiens , human, GenBank number: NP_035831 ; Chlorocebus aethiops , African green monkey, GenBank number: ABA39528 ; Oryctolagus cuniculus , rabbit, GenBank number: XP_002717466 ; Mus musculus , mouse, GenBank number: NP_035831 ; and Mesocricetus auratus , hamster, GenBank number: XP_005081318 . Data represent the mean ± standard deviation from three independent experiments. *, p < 0.05; **, p < 0.01.

    Journal: Viruses

    Article Title: Cell Surface Vimentin Is an Attachment Factor That Facilitates Equine Arteritis Virus Infection In Vitro

    doi: 10.3390/v18010113

    Figure Lengend Snippet: Vimentin expression is a determinant of EAV susceptibility. ( A ) EAV replication kinetics were evaluated in equine (EECs, E. Derm) and non-equine cell lines (BHK-21, HP-RK-13, HEK-293, MCF7, and DLD-1) following infection at a multiplicity of infection (MOI) of 1. ( B ) Immunofluorescence microscopy of EECs E. Derm, DLD-1, and MCF7 cells infected for 12 h with EAV sVBSmCherry and stained with EAV anti-nsp1 MAb (clone 12A4; green), to detect virus replication. Nuclei were counterstained with DAPI (gray). Scale bars = 50 µm. ( C ) Vimentin expression levels were assessed by Western blot. VIM = vimentin. ( D ) Relative quantification of vimentin expression from Western blot analysis. Vimentin levels are expressed as the ratio of each band to β-actin. ( E ) Surface expression of vimentin was quantified by flow cytometry. MFI: Mean Fluorescence Intensity. ( F ) Immunofluorescence microscopy of EECs, E. Derm, DLD-1 and MCF7 cells stained with anti-vimentin MAb (Clone V9) to detect intracellular vimentin (green). Nuclei were counterstained with DAPI (gray). Scale bars = 50 µm. ( G ) Binding assay performed on EECs, E. Derm, DLD-1, and MCF7 cells, with infectious virus titers measured 1 h post-infection at 4 °C. ( H ) Protein alignment of Vimentin from susceptible species and species where a cell line was identified as susceptible to EAV infection. Values represent the percentage of similarity. Equus caballus , horse, GenBank number: NP_001230074 ; Equus asinus , donkey, GenBank number: XP_014701524 ; Homo sapiens , human, GenBank number: NP_035831 ; Chlorocebus aethiops , African green monkey, GenBank number: ABA39528 ; Oryctolagus cuniculus , rabbit, GenBank number: XP_002717466 ; Mus musculus , mouse, GenBank number: NP_035831 ; and Mesocricetus auratus , hamster, GenBank number: XP_005081318 . Data represent the mean ± standard deviation from three independent experiments. *, p < 0.05; **, p < 0.01.

    Article Snippet: Equine dermal fibroblasts (E. Derm, NBL-6 ATCC ® CCL-57, American Type Culture Collection [ATCC ® ], Manassas, VA, USA) and the human breast cancer cell line MCF7 (ATCC ® HTB-22) were propagated in Eagle’s minimal essential medium (EMEM; with Earle’s salts and L-glutamine; Corning) supplemented with 10% fetal bovine serum (FBS), 1 mM of sodium pyruvate and 0.1 mM NEAA.

    Techniques: Expressing, Infection, Immunofluorescence, Microscopy, Staining, Virus, Western Blot, Quantitative Proteomics, Flow Cytometry, Fluorescence, Binding Assay, Standard Deviation